TY - CHAP M1 - Book, Section TI - Chronic Heart Failure A1 - Parker, Robert B. A1 - Rodgers, Jo E. A2 - DiPiro, Joseph T. A2 - Yee, Gary C. A2 - Haines, Stuart T. A2 - Nolin, Thomas D. A2 - Ellingrod, Vicki L. A2 - Posey, L. Michael Y1 - 2023 N1 - T2 - DiPiro’s Pharmacotherapy: A Pathophysiologic Approach, 12th Edition AB - Update SummaryJuly, 2023The following sections, tables, and figures were updated following publication of the ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction:Key concepts 4 and 8 were updated to reflect new guidance on the role of SGLT2 inhibitors for the treatment of HFpEF.Pharmacologic Therapy for HFpEF section was updated to reflect new guidance on the role of SGLT2 inhibitors, ARNI, ARB, and aldosterone antagonist.Table 36-10 was updated to include the DELIVER trial. SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1205561782 ER -